SHG · Healthcare
Drug Manufacturers - Specialty & Generic
Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $14.54B, P/E ratio is 48.96, net margin is 8.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) has a reported market cap of $14.54B (data as of 2026-03-29).
The price-to-earnings (P/E) ratio for Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) is 48.96 (data as of 2026-03-29).
Dividend yield is not available in the current snapshot for Shanghai Haoyuan Chemexpress Co. Ltd. A (688131). Check the MyAverix Finance app for the latest dividend data.
Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
688131 is listed on SHG.
Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) reports a net margin of 8.6% (data as of 2026-03-29).
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.